Skip to Main Content
Skip Nav Destination

Tranexamic Acid



Tranexamic Acid


(tran eks AM ik AS id)

Brand Names: US

  • Cyklokapron
  • Lysteda [DSC]

Therapeutic Category

  • Antifibrinolytic Agent
  • Antihemophilic Agent
  • Hemostatic Agent

Medication Safety Issues

Sound-alike/look-alike issues:

Cyklokapron may be confused with cycloSPORINE

TXA (occasional abbreviation for tranexamic acid) is an error-prone abbreviation (mistaken as TNK an error-prone abbreviation for tenecteplase and tPA an error-prone abbreviation for alteplase)

Administration issues:

Inadvertent administration of tranexamic acid by the epidural or spinal route during neuraxial (eg, epidural, spinal) anesthesia has led to potentially fatal neurotoxic adverse reactions. Carefully evaluate storage procedures within the surgical suite, including separating tranexamic acid from local anesthetics; consider additional prevention measures, including purchasing, dispensing, and administration (ISMP [Smetzer] 2019; NAN Alert 2020; Patel 2019).

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal